The endometrial scraping pathology report, first of all, looks at the description of the pathology and what kind of lesions the endometrium is showing. One is proliferative endometrium or secretory endometrium, which is normal endometrium; the other is endometrial hyperplasia, including simple hyperplasia, complex hyperplasia and endometrial cancer. I. Normal endometrium: Pathological results of endometrial scraping generally show proliferative endometrium, or secretory endometrium. The proliferative endometrium is seen when the menstruation is just clean, which is the first half of the cycle, while the secretory endometrium is seen when the menstruation is about to come, which is the half of the cycle, both are normal endometrium and generally do not need further treatment. Second, abnormal endometrium: 1, mild to moderate: generally will be manifested as mild endometrial hyperplasia, including simple hyperplasia and complex hyperplasia. Simple hyperplasia is a slightly milder lesion and often requires the administration of a second half cycle of progestin supplementation to counteract estrogen. Complex hyperplasia is slightly more severe and requires progestin supplementation for the full menstrual cycle to counteract estrogen. More severe disease is atypical hyperplasia, which is a precancerous lesion of endometrial cancer. For atypical hyperplasia, if there is no requirement for fertility, total hysterectomy is usually performed. If fertility is required to be preserved, high-dose progestin therapy can also be given first, and conception can be performed after the treatment is in remission. After the pregnancy is over, regular observation can be made and hysterectomy can be performed if necessary; 2. Severe: endometrial pathology sometimes shows endometrial cancer, which is the most serious case. For endometrial cancer, standard treatment of endometrial cancer is given. Generally, total hysterectomy plus double adnexal resection plus lymph node dissection should be performed, and whether to supplement radiotherapy or not should be formulated according to the high-risk recurrence after surgery, for example, if the lymph nodes suggest that there is already metastasis after surgery, supplemental radiotherapy is needed.